Allena Pharmaceuticals
$0
35
-$0-99% Wednesday 16:27
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
122.08
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
14AugExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-43.21MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ALNAQ. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Allena Pharmaceuticals, Inc. is a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class, oral biologic therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena's lead product candidate, reloxaliase, is currently being evaluated in a pivotal Phase 3 clinical program for the treatment of enteric hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. Allena is also developing ALLN-346 for the treatment of hyperuricemia in the setting of gout and advanced chronic kidney disease, with a Phase 1 multiple-ascending dose study and a Phase 2a program planned for 2021.
Show more...
CEO
Louis Brenner
Employees
41
Country
United States
ISIN
US0181191075
WKN
000A2H8TL
Listings
0 Comments
Share your thoughts
FAQ
What is Allena Pharmaceuticals stock price today?▼
The current price of ALNAQ is $0 USD — it has decreased by -99% in the past 24 hours. Watch Allena Pharmaceuticals stock price performance more closely on the chart.
What is Allena Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Allena Pharmaceuticals stocks are traded under the ticker ALNAQ.
What is Allena Pharmaceuticals market cap?▼
Today Allena Pharmaceuticals has the market capitalization of 122.08
What is Allena Pharmaceuticals revenue for the last year?▼
Allena Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Allena Pharmaceuticals net income for the last year?▼
ALNAQ net income for the last year is -43.21M USD.
How many employees does Allena Pharmaceuticals have?▼
As of April 29, 2026, the company has 41 employees.
In which sector is Allena Pharmaceuticals located?▼
Allena Pharmaceuticals operates in the Manufacturing sector.
When did Allena Pharmaceuticals complete a stock split?▼
Allena Pharmaceuticals has not had any recent stock splits.
Where is Allena Pharmaceuticals headquartered?▼
Allena Pharmaceuticals is headquartered in Newton, United States.